Adenomatous Polyposis Coli as a Major Regulator of Human Embryonic Stem Cells Self-Renewal.
Adenomatous polyposis coli
CRISPR
Embryonic stem cells
Familial adenomatous polyposis
Pluripotency
Wnt/β-catenin signaling
Journal
Stem cells (Dayton, Ohio)
ISSN: 1549-4918
Titre abrégé: Stem Cells
Pays: England
ID NLM: 9304532
Informations de publication
Date de publication:
12 2019
12 2019
Historique:
received:
23
01
2019
revised:
22
07
2019
accepted:
08
08
2019
pubmed:
29
8
2019
medline:
1
7
2020
entrez:
29
8
2019
Statut:
ppublish
Résumé
Human embryonic stem cells (hESCs) provide an essential tool to investigate early human development, study disease pathogenesis, and examine therapeutic interventions. Adenomatous polyposis coli (APC) is a negative regulator of Wnt/β-catenin signaling, implicated in the majority of sporadic colorectal cancers and in the autosomal dominant inherited syndrome familial adenomatous polyposis (FAP). Studies into the role of Wnt/β-catenin signaling in hESCs arrived at conflicting results, due at least in part to variations in culture conditions and the use of external inhibitors and agonists. Here, we directly targeted APC in hESCs carrying a germline APC mutation, derived from affected blastocysts following preimplantation genetic diagnosis (PGD) for FAP, in order to answer open questions regarding the role of APC in regulating pluripotency and differentiation potential of hESCs. Using clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR associated protein 9 (Cas9), we generated second hit APC mutations in FAP-hESCs. Despite high CRISPR/Cas9 targeting efficiency and the successful isolation of many clones, none of the isolated clones carried a loss of function mutation in the wild-type (WT) APC allele. Using a fluorescent β-catenin reporter and analysis of mutated-allele frequencies in the APC locus, we show that APC double mutant hESCs robustly activate Wnt/β-catenin signaling that results in rapid differentiation to endodermal and mesodermal lineages. Here, we provide direct evidence for a strict requirement for constant β-catenin degradation through the APC destruction complex in order to maintain pluripotency, highlighting a fundamental role for APC in self-renewal of hESCs. Stem Cells 2019;37:1505-1515.
Substances chimiques
CTNNB1 protein, human
0
beta Catenin
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1505-1515Informations de copyright
© AlphaMed Press 2019.
Références
Logan CY, Nusse R. The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 2004;20:781-810.
Clevers H. Wnt/beta-catenin signaling in development and disease. Cell 2006;127:469-480.
Barker N. The canonical Wnt/beta-catenin signalling pathway. Methods Mol Biol 2008;468:5-15.
Groden J, Gelbert L, Thliveris A et al. Mutational analysis of patients with adenomatous polyposis: Identical inactivating mutations in unrelated individuals. Am J Hum Genet 1993;52:263-272.
Olschwang S, Laurent-Puig P, Groden J et al. Germ-line mutations in the first 14 exons of the adenomatous polyposis coli (APC) gene. Am J Hum Genet 1993;52:273-279.
Hornsby C, Page KM, Tomlinson I. The in vivo rate of somatic adenomatous polyposis coli mutation. Am J Pathol 2008;172:1062-1068.
Avior Y, Sagi I, Benvenisty N. Pluripotent stem cells in disease modelling and drug discovery. Nat Rev Mol Cell Biol 2016;17:170-182.
Telias M, Segal M, Ben-Yosef D. Neural differentiation of Fragile X human embryonic stem cells reveals abnormal patterns of development despite successful neurogenesis. Dev Biol 2013;374:32-45.
Eiges R, Urbach A, Malcov M et al. Developmental study of fragile X syndrome using human embryonic stem cells derived from preimplantation genetically diagnosed embryos. Cell Stem Cell 2007;1:568-577.
Avior Y, Lezmi E, Yanuka D et al. Modeling developmental and tumorigenic aspects of trilateral retinoblastoma via human embryonic stem cells. Stem Cell Rep 2017;8:1354-1365.
Crespo M, Vilar E, Tsai SY et al. Colonic organoids derived from human induced pluripotent stem cells for modeling colorectal cancer and drug testing. Nat Med 2017;23:878-884.
Liu M, Tu J, Gingold JA et al. Cancer in a dish: Progress using stem cells as a platform for cancer research. Am J Cancer Res 2018;8:944-954.
Ben-Yosef D, Amit A, Malcov M et al. Female sex bias in human embryonic stem cell lines. Stem Cells Dev 2012;21:363-372.
Yedid N, Kalma Y, Malcov M et al. The effect of a germline mutation in the APC gene on beta-catenin in human embryonic stem cells. BMC Cancer 2016;16:952.
Zorn AM, Wells JM. Vertebrate endoderm development and organ formation. Annu Rev Cell Dev Biol 2009;25:221-251.
Martyn I, Kanno TY, Ruzo A et al. Self-organization of a human organizer by combined Wnt and Nodal signalling. Nature 2018;558:132-135.
van Boxtel AL, Economou AD, Heliot C et al. Long-range signaling activation and local inhibition separate the mesoderm and endoderm lineages. Dev Cell 2018;44:179-191 e175.
Wikramanayake AH, Hong M, Lee PN et al. An ancient role for nuclear beta-catenin in the evolution of axial polarity and germ layer segregation. Nature 2003;426:446-450.
Rocheleau CE, Downs WD, Lin R et al. Wnt signaling and an APC-related gene specify endoderm in early C. elegans embryos. Cell 1997;90:707-716.
Sherwood RI, Maehr R, Mazzoni EO et al. Wnt signaling specifies and patterns intestinal endoderm. Mech Dev 2011;128:387-400.
Engert S, Burtscher I, Liao WP et al. Wnt/beta-catenin signalling regulates Sox17 expression and is essential for organizer and endoderm formation in the mouse. Development 2013;140:3128-3138.
Wang Z, Oron E, Nelson B et al. Distinct lineage specification roles for NANOG, OCT4, and SOX2 in human embryonic stem cells. Cell Stem Cell 2012;10:440-454.
James D, Levine AJ, Besser D et al. TGFbeta/activin/nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem cells. Development 2005;132:1273-1282.
Ohtsuka S, Dalton S. Molecular and biological properties of pluripotent embryonic stem cells. Gene Ther 2008;15:74-81.
Noggle SA, James D, Brivanlou AH. A molecular basis for human embryonic stem cell pluripotency. Stem Cell Rev 2005;1:111-118.
Singh AM, Reynolds D, Cliff T et al. Signaling network crosstalk in human pluripotent cells: A Smad2/3-regulated switch that controls the balance between self-renewal and differentiation. Cell Stem Cell 2012;10:312-326.
Hao J, Li TG, Qi X et al. WNT/beta-catenin pathway up-regulates Stat3 and converges on LIF to prevent differentiation of mouse embryonic stem cells. Dev Biol 2006;290:81-91.
Sato N, Meijer L, Skaltsounis L et al. Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat Med 2004;10:55-63.
Ying QL, Wray J, Nichols J et al. The ground state of embryonic stem cell self-renewal. Nature 2008;453:519-523.
Ten Berge D, Kurek D, Blauwkamp T et al. Embryonic stem cells require Wnt proteins to prevent differentiation to epiblast stem cells. Nat Cell Biol 2011;13:1070-1075.
Kielman MF, Rindapaa M, Gaspar C et al. Apc modulates embryonic stem-cell differentiation by controlling the dosage of beta-catenin signaling. Nat Genet 2002;32:594-605.
Fernandez A, Huggins IJ, Perna L et al. The WNT receptor FZD7 is required for maintenance of the pluripotent state in human embryonic stem cells. Proc Natl Acad Sci USA 2014;111:1409-1414.
Davidson KC, Adams AM, Goodson JM et al. Wnt/beta-catenin signaling promotes differentiation, not self-renewal, of human embryonic stem cells and is repressed by Oct4. Proc Natl Acad Sci USA 2012;109:4485-4490.
Blauwkamp TA, Nigam S, Ardehali R et al. Endogenous Wnt signalling in human embryonic stem cells generates an equilibrium of distinct lineage-specified progenitors. Nat Commun 2012;3:1070.
Kim H, Wu J, Ye S et al. Modulation of beta-catenin function maintains mouse epiblast stem cell and human embryonic stem cell self-renewal. Nat Commun 2013;4:2403.
Abu-Remaileh M, Gerson A, Farago M et al. Oct-3/4 regulates stem cell identity and cell fate decisions by modulating Wnt/beta-catenin signalling. EMBO J 2010;29:3236-3248.
Ben-Yosef D, Boscolo FS, Amir H et al. Genomic analysis of hESC pedigrees identifies de novo mutations and enables determination of the timing and origin of mutational events. Cell Rep 2013;4:1288-1302.
Wyvekens N, Tsai SQ, Joung JK. Genome editing in human cells using CRISPR/Cas nucleases. Curr Protoc Mol Biol 2015;112:31.33.3.1-31.33.3.18.
Ran FA, Hsu PD, Wright J et al. Genome engineering using the CRISPR-Cas9 system. Nat Protoc 2013;8:2281-2308.
Pinello L, Canver MC, Hoban MD et al. Analyzing CRISPR genome-editing experiments with CRISPResso. Nat Biotechnol 2016;34:695-697.
Fearnhead NS, Britton MP, Bodmer WF. The ABC of APC. Hum Mol Genet 2001;10:721-733.
Crabtree M, Sieber OM, Lipton L et al. Refining the relation between 'first hits’ and 'second hits’ at the APC locus: The 'loose fit’ model and evidence for differences in somatic mutation spectra among patients. Oncogene 2003;22:4257-4265.
Chandra SH, Wacker I, Appelt UK et al. A common role for various human truncated adenomatous polyposis coli isoforms in the control of beta-catenin activity and cell proliferation. PLoS One 2012;7:e34479.
Kohler EM, Chandra SH, Behrens J et al. Beta-catenin degradation mediated by the CID domain of APC provides a model for the selection of APC mutations in colorectal, desmoid and duodenal tumours. Hum Mol Genet 2009;18:213-226.
Fuerer C, Nusse R. Lentiviral vectors to probe and manipulate the Wnt signaling pathway. PLoS One 2010;5:e9370.
Chen B, Dodge ME, Tang W et al. Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer. Nat Chem Biol 2009;5:100-107.
The International Stem Cell I, Adewumi O, Aflatoonian B et al. Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nat Biotechnol 2007;25:803-816.
Newman AM, Cooper JB. Lab-specific gene expression signatures in pluripotent stem cells. Cell Stem Cell 2010;7:258-262.
Jiang W, Zhang D, Bursac N et al. WNT3 is a biomarker capable of predicting the definitive endoderm differentiation potential of hESCs. Stem Cell Rep 2013;1:46-52.
Sommer CA, Capilla A, Molina-Estevez FJ et al. Modeling APC mutagenesis and familial adenomatous polyposis using human iPS cells. PLoS One 2018;13:e0200657.
Tan JY, Sriram G, Rufaihah AJ et al. Efficient derivation of lateral plate and paraxial mesoderm subtypes from human embryonic stem cells through GSKi-mediated differentiation. Stem Cells Dev 2013;22:1893-1906.
Naujok O, Diekmann U, Lenzen S. The generation of definitive endoderm from human embryonic stem cells is initially independent from activin A but requires canonical Wnt-signaling. Stem Cell Rev 2014;10:480-493.